Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] LEENO Industrial (058470) – Change in Profit/Loss Structure over 30% (15% for Large Companies) / 2026-02-10

Posted on February 10, 2026August 4, 2026 By K-STOCK Editor No Comments on [Disclosure] LEENO Industrial (058470) – Change in Profit/Loss Structure over 30% (15% for Large Companies) / 2026-02-10

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Driven by expanded customer orders and process improvements, LEENO Industrial’s FY2025 separate operating profit increased by 42.5% YoY to KRW 177.0 billion.

📊 [Key Disclosure Details & Financial Figures]

  • Separate Income & Profit/Loss Changes (Unit: KRW, %):
    • Revenue: KRW 372,534,084,608 (+33.9% YoY vs. KRW 278,186,189,427)
    • Operating Income: KRW 176,997,188,289 (+42.5% YoY vs. KRW 124,201,343,872)
    • Income Before Income Taxes: KRW 195,856,560,281 (+33.6% YoY vs. KRW 146,539,081,944)
    • Net Income: KRW 151,960,670,406 (+34.1% YoY vs. KRW 113,279,046,428)
    • Large Corporation Status: Not Applicable
  • Financial Position (Unit: KRW):
    • Total Assets: KRW 791,928,165,325
    • Total Liabilities: KRW 60,709,212,955
    • Total Equity: KRW 731,218,952,370
    • Capital Stock: KRW 7,621,185,000
  • Primary Cause of Change: Revenue and profitability expansion due to increased client orders and manufacturing process improvements
  • Board Resolution Date: February 10, 2026 (2 Outside Directors present, Statutory Auditor present)
  • Other Key Details: Figures represent preliminary unaudited separate performance prepared under K-IFRS and remain subject to change during external audit and AGM approval

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of External Audit Results and Final Annual Report Filing

The company announced strong FY2025 performance attributed to order expansion and operational efficiency gains. As the reported figures are preliminary estimates prior to external audit completion, verifying the final audited financial statements and auditor’s opinion is essential. Relevant details can be cross-checked in the upcoming disclosures for ‘Submission of Audit Report’ and the official Annual Report filed on DART.

📢 Disclaimer and Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK square (402340) – Change in Revenues or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-02-10
Next Post: [Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2026-02-10

Related Posts

[Disclosure] Hanwha Ocean (042660) – Decision on Capital Increase / 2025-02-18 Disclosures
[Disclosure] Hanwha Ocean (042660) – (Correction) Signing of Single Sales/Supply Contract / 2025-03-18 Disclosures
[Disclosure] SK Square (402340) – Treasury Stock Disposal Decision / 2025-10-29 Semiconductors
[Disclosure] Hanwha Systems (272210) – Setting of Record Date and Closure of Shareholders’ Register for 26th AGM Voting Rights Disclosures
[Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-12-19 Semiconductors
[Disclosure] Hanwha Ocean (042660) Amends Counterparty and Region for LNG Carrier Contract (Contract Value Unchanged at KRW 526.3B) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme